日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Serologic Evidence of Hemorrhagic Fever Virus Spillover in Rural Liberia

利比里亚农村地区出血热病毒溢出的血清学证据

Schafer, Adam M; Kerkula, Emmanuel; Lee, Chanhwa; Flomo, Alfred; Fofana, Amara; Kerkula, Stanley; Sumo, Thomas; Sampson, Alexander; Vouh, Samuel; Flomo, Fred; Colt, McKenzie A; Mollan, Katie R; Krajewski, Taylor J; Watts, Eleanor Rose; Nimely, Catherine; Schoepp, Randal J; Ricks, Keersten; Ricks, Minnie; Sibley, Jefferson; Dillard, Jacob A; Wohl, David A; Fischer, William A 2nd

Viral shedding and symptom severity across populations during acute COVID in the ACTIV-2 study

ACTIV-2 研究中急性 COVID 期间不同人群的病毒脱落和症状严重程度

Kung, Evelyn; Deo, Rinki; Choudhary, Manish C; Chew, Kara W; Evering, Teresa H; Ignacio, Rachel Bender; Jagannathan, Prasanna; Flynn, James P; Regan, James; Moser, Carlee; Giganti, Mark J; Hughes, Michael D; Ritz, Justin; Javan, Arzhang Cyrus; Greninger, Alexander L; Singh, Upinder; Fischer, William; Daar, Eric S; Wohl, David A; Eron, Joseph J; Currier, Judith S; Coombs, Robert W; Smith, Davey M; Li, Jonathan Z

Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial.

在随机安慰剂对照试验中,使用抗严重急性呼吸综合征冠状病毒 2 单克隆抗体疗法后出现病毒和症状反弹

Chew Kara W, McGinley Brooke, Moser Carlee, Li Jonathan Z, Evering Teresa H, Ritz Justin, Javan Arzhang Cyrus, Margolis David, Wohl David A, Hughes Michael D, Daar Eric S, Currier Judith S, Eron Joseph J, Smith Davey M

Correction: A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol

更正:一项前瞻性、多中心队列研究,旨在评估西非国家拉沙热病毒感染和疾病的发生率(拉沙热研究项目)——研究方案

Penfold, Suzanne; Adegnika, Ayola Akim; Asogun, Danny; Ayodeji, Olufemi; Azuogu, Benedict N; Fischer, William A 2nd; Garry, Robert F; Grant, Donald Samuel; Happi, Christian; N'Faly, Magassouba; Olayinka, Adebola; Samuels, Robert; Sibley, Jefferson; Wohl, David A; Accrombessi, Manfred; Adetifa, Ifedayo; Annibaldis, Giuditta; Camacho, Anton; Dan-Nwafor, Chioma; Deha, Akpénè Ruth Esperencia; DeMarco, Jean; Duraffour, Sophie; Goba, Augustine; Grais, Rebecca; Günther, Stephan; Honvou, Énagnon Junior Juvénal Prince; Ihekweazu, Chikwe; Jacobsen, Christine; Kanneh, Lansana; Momoh, Mambu; Ndiaye, Aminata; Nsaibirni, Robert; Okogbenin, Sylvanus; Ochu, Chinwe; Ogbaini, Ephraim; Logbo, Énagnon Parsifal Marie Alexandre; Sandi, John Demby; Schieffelin, John S; Verstraeten, Thomas; Vielle, Nathalie J; Yadouleton, Anges; Yovo, Emmanuel Koffi

Research protocol design and implementation of a hybrid no-touch and low-touch prospective observational study during the COVID-19 public health emergency: the VISION study

在 COVID-19 公共卫生紧急事件期间,设计并实施一项混合型非接触和低接触前瞻性观察研究的研究方案:VISION 研究

Straub, Becky; Mollan, Katie R; Keys, Jessica R; Lee, Chanhwa; Swanstrom, Ronald; Premkumar, Lakshmanane; Sheahan, Timothy P; Zhou, Shuntai; Fischer, William A; Wohl, David A

Health and economic impacts of Lassa vaccination campaigns in West Africa

西非拉沙疫苗接种运动的健康和经济影响

Smith, David R M; Turner, Joanne; Fahr, Patrick; Attfield, Lauren A; Bessell, Paul R; Donnelly, Christl A; Gibb, Rory; Jones, Kate E; Redding, David W; Asogun, Danny; Ayodeji, Oladele Oluwafemi; Azuogu, Benedict N; Fischer, William A 2nd; Jan, Kamji; Olayinka, Adebola T; Wohl, David A; Torkelson, Andrew A; Dinkel, Katelyn A; Nixon, Emily J; Pouwels, Koen B; Hollingsworth, T Déirdre

Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial

ACTIV-2 试验中,amubarvimab/romlusevimab 与安慰剂相比,对 COVID-19 急性期后结局(包括参与者报告的长期 COVID)的影响

Evering, Teresa H; Moser, Carlee; Jilg, Nikolaus; Ritz, Justin; Wohl, David A; Li, Jonathan Z; Margolis, David; Javan, Arzhang Cyrus; Eron, Joseph J; Currier, Judith S; Daar, Eric S; Smith, Davey M; Hughes, Michael D; Chew, Kara W

High Body Mass Index and Response to Anti-Tumor Necrosis Factor Therapy in Pediatric Crohn's Disease

高体重指数与儿童克罗恩病抗肿瘤坏死因子治疗反应的关系

Ebach, Dawn R; Jester, Traci W; Galanko, Joseph A; Firestine, Ann M; Ammoury, Rana; Cabrera, Jose; Bass, Julie; Minar, Phillip; Olano, Kelly; Margolis, Peter; Sandberg, Kelly; Linnville, Tiffany M; Kaplan, Jess; Pitch, Lisa; Steiner, Steven J; Bass, Dorsey; Moses, Jonathan; Adler, Jeremy; Gulati, Ajay S; Wali, Prateek; Pashankar, Dinesh; Ivanova, Anastasia; Herfarth, Hans; Wohl, David A; Benkov, Keith J; Strople, Jennifer; Sullivan, Jillian; Tung, Jeanne; Molle-Rios, Zorela; Saeed, Shehzad A; Bousvaros, Athos; Kappelman, Michael D

Ebola Virus-Specific Neutralizing Antibody Persists at High Levels in Survivors 2 Years After Resolution of Disease in a Sierra Leonean Cohort

在塞拉利昂人群中,埃博拉病毒特异性中和抗体在疾病痊愈两年后仍维持在高水平。

Bond, Nell G; Shore, Kayla R; Engel, Emily J; Coonan, Erin E; Al-Hasan, Foday; Gbakie, Michael A; Kamara, Fatima K; Kanneh, Lansana; Momoh, Mambu; Kanneh, Ibrahim M; Sandi, John D; Elliott, Debra; Ficenec, Samuel C; Smira, Ashley R; Fischer, William A; Wohl, David A; Robinson, James E; Shaffer, Jeffrey G; Garry, Robert F; Samuels, Robert J; Grant, Donald S; Schieffelin, John S

SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback

SARS-CoV-2单克隆抗体治疗后接种疫苗可改变人类记忆B细胞对表位的识别,提示存在抗体反馈机制。

Bloom, Nathaniel; Ramirez, Sydney I; Cohn, Hallie; Parikh, Urvi M; Heaps, Amy; Sieg, Scott F; Greninger, Alex; Ritz, Justin; Moser, Carlee; Eron, Joseph J; Bajic, Goran; Currier, Judith S; Klekotka, Paul; Wohl, David A; Daar, Eric S; Li, Jonathan; Hughes, Michael D; Chew, Kara W; Smith, Davey M; Crotty, Shane; Coelho, Camila H